Healthcare provider profile · identity verified

Robert N. Hunold, D.O.

Family Practice · DAMARISCOTTA, ME · NPI 1013107879

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	590	166
Levothyroxine Sodium	Levothyroxine Sodium	339	81
Omeprazole	Omeprazole	333	82
Lisinopril	Lisinopril	316	87
Amlodipine Besylate	Amlodipine Besylate	286	97
Metoprolol Succinate	Metoprolol Succinate	237	71
Escitalopram Oxalate	Escitalopram Oxalate	224	68
Hydrochlorothiazide	Hydrochlorothiazide	205	61
Gabapentin	Gabapentin	203	51
Prednisone	Prednisone	198	106
Losartan Potassium	Losartan Potassium	165	50
Lorazepam	Lorazepam	163	39
Eliquis	Apixaban	159	44
Tamsulosin Hcl	Tamsulosin Hcl	158	50
Albuterol Sulfate Hfa	Albuterol Sulfate	133	49
Metformin Hcl	Metformin Hcl	131	37
Oxycodone Hcl	Oxycodone Hcl	126	27
Simvastatin	Simvastatin	124	35
Rosuvastatin Calcium	Rosuvastatin Calcium	119	41
Furosemide	Furosemide	115	35
Alprazolam	Alprazolam	112	24
Zolpidem Tartrate	Zolpidem Tartrate	109	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	106	41
Sertraline Hcl	Sertraline Hcl	96	30
Metoprolol Tartrate	Metoprolol Tartrate	95	27
Allopurinol	Allopurinol	94	29
Donepezil Hcl	Donepezil Hcl	93	16
Pantoprazole Sodium	Pantoprazole Sodium	90	27
Torsemide	Torsemide	88	27
Glipizide Er	Glipizide	85	20
Atenolol	Atenolol	83	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	83	19
Quetiapine Fumarate	Quetiapine Fumarate	77	suppressed
Mirtazapine	Mirtazapine	72	15
Doxycycline Hyclate	Doxycycline Hyclate	65	54
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	24
Trazodone Hcl	Trazodone Hcl	64	15
Finasteride	Finasteride	63	17
Triamcinolone Acetonide	Triamcinolone Acetonide	62	31
Azithromycin	Azithromycin	59	52
Carvedilol	Carvedilol	59	17
Metformin Hcl Er	Metformin Hcl	57	18
Duloxetine Hcl	Duloxetine Hcl	51	11
Clopidogrel	Clopidogrel Bisulfate	50	20
Warfarin Sodium	Warfarin Sodium	50	18
Citalopram Hbr	Citalopram Hydrobromide	48	14
Jardiance	Empagliflozin	47	11
Bupropion Xl	Bupropion Hcl	46	14
Fluoxetine Hcl	Fluoxetine Hcl	45	suppressed
Pravastatin Sodium	Pravastatin Sodium	45	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	26
Synthroid	Levothyroxine Sodium	41	14
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Tramadol Hcl	Tramadol Hcl	37	18
Xarelto	Rivaroxaban	37	suppressed
Glipizide	Glipizide	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Nifedipine Er	Nifedipine	33	suppressed
Spironolactone	Spironolactone	33	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	31
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	21
Amoxicillin	Amoxicillin	31	25
Clozapine	Clozapine	31	suppressed
Olanzapine	Olanzapine	31	suppressed
Potassium Chloride	Potassium Chloride	31	suppressed
Risperidone	Risperidone	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	17
Diazepam	Diazepam	27	11
Nystatin	Nystatin	27	13
Chlorthalidone	Chlorthalidone	26	suppressed
Nitroglycerin	Nitroglycerin	26	13
Clonazepam	Clonazepam	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	14
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	12
Meloxicam	Meloxicam	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Breyna	Budesonide/Formoterol Fumarate	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Famotidine	Famotidine	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Lactulose	Lactulose	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Insulin Aspart Prot Mix 70-30	Insulin Aspart Prot/Insuln Asp	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Clonidine	Clonidine	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Morphine Sulfate	Morphine Sulfate	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Ozempic	Semaglutide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	11
Aripiprazole	Aripiprazole	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Valsartan	Valsartan	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Humira(Cf) Pen	Adalimumab	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error